← Back to Clinical Trials
Recruiting NCT07495059

Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition HIV (Human Immunodeficiency Virus)
Sponsor University of California, Los Angeles
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex MALE
Min Age 16 Years
Max Age N/A
Start Date 2026-03-01
Completion 2026-10-01
Interventions
TransAction

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Transgender women in the intervention condition will attend TransAction individual risk reduction sessions; skill building and open group support sessions, and social events between baseline and 3-month assessment. Transgender women participants in the control condition will be invited to social events only.

Eligibility Criteria

Inclusion Criteria: * 16 years of age or older * being male at birth and currently self-identified as a TW * currently living in Ho Chi Minh City adjacent areas and having no plans to move out of the areas in the next 6 months - have the cognitive capacity to participate in study activities as judged by the study recruiter. Exclusion Criteria: * have been involved in intervention adaptation activities previously with the study team * inability to give informed consent/assent

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE HIV (HUMAN IMMUNODEFICIENCY VIRUS) TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}